CVS HEALTH CORPORATION $1,500,000,000 1.300% Senior Notes due 2027 $1,250,000,000 1.750% Senior Notes due 2030 $1,250,000,000 2.700% Senior Notes due 2040 Underwriting AgreementUnderwriting Agreement • August 14th, 2020 • CVS HEALTH Corp • Retail-drug stores and proprietary stores • New York
CVS Health Corporation, a Delaware corporation (the “Company”), proposes to issue and sell $1,500,000,000 aggregate principal amount of its 1.300% Senior Notes due 2027 (the “2027 Notes”), $1,250,000,000 aggregate principal amount of its 1.750% Senior Notes due 2030 (the “2030 Notes”) and $1,250,000,000 aggregate principal amount of its 2.700% Senior Notes due 2040 (the “2040 Notes” and, together with the 2027 Notes and 2030 Notes, the “Notes”) to the several underwriters named on Schedule I hereto (the “Underwriters”), for which Barclays Capital Inc., BofA Securities, Inc. and Goldman Sachs & Co. LLC are acting as representatives (the “Representatives”). The Notes will (a) have terms and provisions which are summarized in the Disclosure Package as of the Applicable Time and the Prospectus dated as of the date hereof (each as defined in Section 1(a) hereof) and (b) be issued pursuant to an Indenture dated as of August 15, 2006 (the “Indenture”) between the Company and The Bank of New Y
